Nucala multiple strengths Images
Generic Name: mepolizumab
This medication has been identified as Nucala multiple strengths. It is supplied by GlaxoSmithKline.
Nucala is used in the treatment of Chronic Rhinosinusitis With Nasal Polyps; Hypereosinophilic Syndrome; Asthma; Asthma, Maintenance; Eosinophilic Granulomatosis with Polyangiitis and belongs to the drug class interleukin inhibitors. FDA has not classified the drug for risk during pregnancy. Nucala multiple strengths is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Nucala
- Generic Name
- mepolizumab
- Strength
- multiple strengths
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- multiple
See also:
More about Nucala (mepolizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (100)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.